14.84USD+2.34%Mkt Cap: 1.93B $P/E: —1d ago
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clin…
Industry Peers
Diagnostics & Research$201.86BUSDP/E 29.8
$145.10BUSDP/E 39.7
$45.85BUSDP/E 44.2
$45.44BUSDP/E 42.4
$38.64BUSD
$38.44BUSDP/E 27.3
$37.13BUSDP/E 48.1
$35.13BUSDP/E 26.2
$28.78BUSDP/E 34.6
$26.98BUSDP/E 31.4
$23.18BUSDP/E 23.1
$23.12BUSDP/E 25.0
$20.55BUSD
$15.36BUSDP/E 33.9
$13.06BUSDP/E 27.3
$12.46BUSDP/E 53.7
$11.04BUSD
$9.26BUSDP/E 21.6
$5.90BUSDP/E 237.4
$5.68BUSD
$5.21BUSDP/E 44.6
$4.95BUSD
$4.73BUSDP/E 54.8
$3.75BUSDP/E 26.5
$3.54BUSD
$3.09BUSD
$2.08BUSD
$1.83BUSD
$1.64BUSDP/E 41.7
$1.63BUSD
$1.48BUSDP/E 22.4
$1.02BUSDP/E 21.4
$898.56MUSD
$734.89MUSD
$616.40MUSDP/E 40.2
$584.63MUSD
$583.63MUSD
$293.12MUSDP/E 2.9
$292.75MUSD
$206.70MUSD
$152.09MUSD
$139.43MUSD
$97.25MUSD
$102.68MUSD
$89.37MUSDP/E 17.2
$73.19MUSD
$58.55MUSD
$42.32MUSD
$30.71MUSD
$26.61MUSD
$20.94MUSD
$16.60MUSD
$12.04MUSD
$9.95MUSD
$8.70MUSD
$8.87MUSD
$7.73MUSD
$7.43MUSD
$6.69MUSD
$6.06MUSD
$5.06MUSD
$4.47MUSD
$4.44MUSD
$2.95MUSD
$3.29MUSD
$3.18MUSD
$869.0KUSD
$314.2KUSDP/E Infinity
$19.6KUSD
Indicators:|
Key Statistics
Company
Market Cap1.93B $
Enterprise Value2.19B $
Revenue (TTM)745.97M $
Gross Profit314.29M $
Net Income (TTM)-108.03M $
Revenue/Share5.803 USD
Last Price14.84 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.5K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)40.71
PEG2.09
EV/EBITDA514.35
EV/Revenue2.94
P/S2.59
P/B2.32
EPS (TTM)-0.77
EPS (Forward)0.36
52W Range
4.72093% of range15.57
52W High15.57 USD
52W Low4.720 USD
Profitability
Gross Margin43.21%
Oper. Margin-9.34%
EBITDA Margin0.57%
Profit Margin-14.85%
ROE-12.91%
ROA-7.94%
Growth
Revenue Growth11.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF5.23M $
CapEx (TTM)27.01M $
FCF Margin4.45%
FCF Yield1.72%
Net Debt262.39M $
Net Debt/EBITDA61.49
Balance Sheet
Debt/Equity0.49
Current Ratio4.42
Quick Ratio3.71
Book Value/Sh6.392 USD
Cash/Share1.122 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)16.22 USD
Upside (mean)+9.3%
Target Range11.00 USD – 25.00 USD
$11.00+9.3% to mean$25.00
# Analysts9
Ownership
Shares Out.130.21M
Float118.27M
Insiders2.05%
Institutions108.22%
Short Interest
Short Ratio3.4d
Short % Float10.51%
Short % Out.8.92%
Shares Short11.62M
Short (prev mo.)8.49M
Technical
SMA 5011.22 (+32.3%)
SMA 20010.50 (+41.4%)
Beta1.74
S&P 52W Chg20.25%
Avg Vol (30d)3.02M
Avg Vol (10d)2.33M
Technical Indicators
RSI (14)70.2
MACD1.0216
MACD Signal1.1044
MACD Hist.-0.0829
BB Upper16.80 USD
BB Middle13.53 USD
BB Lower10.26 USD
BB Width48.28%
ATR (14)0.6488 USD
Vol Ratio (20d)1.14x